WWLN1080AM /WDZY1290AM /103.3FM KWDF 840AM/99.7FM/WBRI1500 AM&WBRI 96.7 FM 05/30/2020

Our first guest is Michelle Armer is Chief People Officer at CareerBuilder. A 20-year veteran in the HR space, she leads the Talent Team with a focus on building a high-performance culture that supports business goals, employees’ professional development, and diversity. She will discuss how college seniors can navigate the job market during this tumultuous time. She can share tried and true tips for standing out as well as new tools to leverage in this trepidatious time in the labor market. Her passion for engaging employees and developing positive work environments drives her commitment to CareerBuilder’s employees, candidates, and clients. For more information please visit www.CareerBuilder.com


Our final guests today are  Andy Vicari, Senior Director & U.S. Brand Leader, Insulins, Eli Lilly and Company. Joining Mr. Vicari is Dr. Anne Peters.  Contracting and treating COVID-19 can be worrisome for people with diabetes, as these individuals are more likely to experience complications. With this in mind, Eli Lilly and Company and Beyond Type 1, a diabetes advocacy group, are working to ensure that people living with diabetes are prepared to manage their condition throughout the COVID-19 pandemic.

Anne Peters, MD, Beyond Type 1 Science Advisory Committee, and Mr. Vicari will discuss how Cov-19 as it relates to the diabetes community as well as affordable resources for people who use Lilly insulin. Lilly recently introduced the new Lilly Insulin Value Program, allowing anyone with commercial insurance, or who is uninsured, to fill their monthly prescription of Lilly insulin for $35. Beyond Type 1 is also addressing the medical considerations of people with diabetes, providing the community with the information they need to proactively care for their health amid the COVID-19 crisis. For more information please visit www.insulinaffordability.com 

Listen Now

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *

CAPTCHA * Time limit is exhausted. Please reload CAPTCHA.